AMLX
Price
$4.56
Change
-$0.31 (-6.37%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
433.84M
Earnings call today
BEAM
Price
$17.25
Change
+$1.02 (+6.28%)
Updated
May 8 closing price
Capitalization
1.63B
95 days until earnings call
Ad is loading...

AMLX vs BEAM

Header iconAMLX vs BEAM Comparison
Open Charts AMLX vs BEAMBanner chart's image
Amylyx Pharmaceuticals
Price$4.56
Change-$0.31 (-6.37%)
Volume$86.53K
Capitalization433.84M
Beam Therapeutics
Price$17.25
Change+$1.02 (+6.28%)
Volume$3.15M
Capitalization1.63B
AMLX vs BEAM Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. BEAM commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Hold and BEAM is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (AMLX: $4.87 vs. BEAM: $17.25)
Brand notoriety: AMLX and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 278% vs. BEAM: 119%
Market capitalization -- AMLX: $433.84M vs. BEAM: $1.63B
AMLX [@Biotechnology] is valued at $433.84M. BEAM’s [@Biotechnology] market capitalization is $1.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • AMLX’s TA Score: 3 bullish, 7 bearish.
  • BEAM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а -4.70% price change this week, while BEAM (@Biotechnology) price change was -13.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.88%. For the same industry, the average monthly price growth was +15.29%, and the average quarterly price growth was -13.75%.

Reported Earning Dates

AMLX is expected to report earnings on Aug 07, 2025.

BEAM is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-3.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.63B) has a higher market cap than AMLX($434M). AMLX YTD gains are higher at: 28.836 vs. BEAM (-30.444). AMLX has higher annual earnings (EBITDA): -290.98M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. AMLX (177M). AMLX has less debt than BEAM: AMLX (1.98M) vs BEAM (161M). AMLX has higher revenues than BEAM: AMLX (87.4M) vs BEAM (63.5M).
AMLXBEAMAMLX / BEAM
Capitalization434M1.63B27%
EBITDA-290.98M-383.98M76%
Gain YTD28.836-30.444-95%
P/E Ratio2.69N/A-
Revenue87.4M63.5M138%
Total Cash177M851M21%
Total Debt1.98M161M1%
TECHNICAL ANALYSIS
Technical Analysis
AMLXBEAM
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 15 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BLYPX30.290.16
+0.53%
American Beacon Man Lg Cp Growth Inv
SFILX13.96N/A
N/A
Schwab Fundamental Intl Sm Eq Idx
NBSRX47.87N/A
N/A
Neuberger Berman Sustainable Equity Inv
FUFRX24.04N/A
N/A
Franklin Utilities R6
EMQCX7.92N/A
N/A
Ashmore Emerging Markets Active Eq C

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+4.73%
XOMAO - AMLX
68%
Closely correlated
+0.49%
IKNA - AMLX
54%
Loosely correlated
-2.68%
XOMAP - AMLX
51%
Loosely correlated
N/A
RGNX - AMLX
47%
Loosely correlated
-8.59%
PRME - AMLX
46%
Loosely correlated
+6.77%
More